- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00122122
Randomized Controlled Trial of Enhanced Pharmacy Care in Older Veteran Outpatients
Complications resulting from medications, or adverse drug events (ADEs), are prevalent and are a major source of excess morbidity and costs. ADEs are particularly problematic in older patients because of their higher burden of comorbidity and diminished physiologic reserve. In addition, older patients are more likely to be exposed to polypharmacy, a major risk factor for ADEs. While ADEs may be idiosyncratic, many result from medical errors and inadequate systems for ensuring the safe and effective use of medications.
The goal of the proposed study is to test the efficacy of a potentially potent intervention to improve the use of medications in older outpatients enrolled in VA primary care clinics. The intervention-Enhanced Pharmacy Care-involves a formal, multi-dimensional evaluation of patients� medication regimens by a trained clinical pharmacist and board-certified geriatrician.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background:
Complications resulting from medications, or adverse drug events (ADEs), are prevalent and are a major source of excess morbidity and costs. ADEs are particularly problematic in older patients because of their higher burden of comorbidity and diminished physiologic reserve. In addition, older patients are more likely to be exposed to polypharmacy, a major risk factor for ADEs. While ADEs may be idiosyncratic, many result from medical errors and inadequate systems for ensuring the safe and effective use of medications.
The goal of the proposed study is to test the efficacy of a potentially potent intervention to improve the use of medications in older outpatients enrolled in VA primary care clinics. The intervention-Enhanced Pharmacy Care-involves a formal, multi-dimensional evaluation of patients� medication regimens by a trained clinical pharmacist and board-certified geriatrician.
Objectives:
The study has the following six aims: 1) Compare changes in prescribing practices-as measured by medication appropriateness, number of medications, and cost of prescribed medications-between baseline and follow-up in patients randomized to Enhanced Pharmacy Care and patients randomized to usual care; 2) Compare other medication-based endpoints in the two groups, including the occurrence of potential ADEs, medication compliance, and patient knowledge of medications; 3) Compare changes in health-related-quality-of-life in the two groups; 4) Compare patient perceptions of the quality of VA outpatient care in the two groups; 5) Compare health care utilization during the one-year study period in the two groups; and 6) Examine attitudes of primary care providers (PCPs) about the intervention.
Methods:
Patients were eligible for the trial if they were 65 years and older and receiving prescriptions for > 5 medications in a VA primary care clinic. Patients were randomized to usual care or to the intervention, which included a structured medication history and medical records review. For intervention patients, therapeutic recommendations were developed and presented to primary care providers. Baseline and 3-month measures were obtained and change was assessed by analysis of covariance.
Status:
493 patients have been enrolled in the trial and 12-month follow-up has been completed on over 95% of patients. Preliminary results have been evaluated and abstracts have been submitted to national meetings, including the 2004 VA HSR&D and 2004 SGIM Annual Meetings where it will be presented as an oral presentation. We are completing all the data cleaning and will be performing final analyses on the data, with manuscript preparation. Final outcome assessment using the Medication Appropriateness Index is in the final stage.
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Iowa
-
Iowa City, Iowa, United States, 52246-2208
- Iowa City VA Health Care System, Iowa City, IA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Patients enrolled in VA primary care clinics who are 65 years and older and who are receiving prescriptions for 5 or more scheduled medications.
Exclusion Criteria:
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Arm 1
|
Collaborators and Investigators
Investigators
- Principal Investigator: Gary E. Rosenthal, MD, Iowa City VA Health Care System, Iowa City, IA
Publications and helpful links
General Publications
- Steinman MA, Rosenthal GE, Landefeld CS, Bertenthal D, Kaboli PJ. Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing. Arch Intern Med. 2009 Jul 27;169(14):1326-32. doi: 10.1001/archinternmed.2009.206.
- Steinman MA, Rosenthal GE, Landefeld CS, Bertenthal D, Sen S, Kaboli PJ. Conflicts and concordance between measures of medication prescribing quality. Med Care. 2007 Jan;45(1):95-9. doi: 10.1097/01.mlr.0000241111.11991.62.
Study record dates
Study Major Dates
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SAF 98-152
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Geriatrics
-
KTO Karatay UniversityCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
-
GenfitCompleted
-
Centre Francois BaclesseCompleted
-
Jewish General HospitalActive, not recruiting
-
Hospices Civils de LyonCompleted
-
Istanbul University - Cerrahpasa (IUC)Completed
-
University Hospital, LilleCompleted
-
Bruyere Research InstituteBaycrest; West Park Healthcare CentreCompletedPhysical Activity | Aging | GeriatricsCanada
-
Centre Hospitalier Universitaire DijonWithdrawn
Clinical Trials on Enhanced Pharmacy Care
-
Stephen J. Teach, MD, MPHNational Association of Chain Drug StoresCompleted
-
San Francisco Veterans Affairs Medical CenterUniversity of California, San FranciscoUnknown
-
Massachusetts General HospitalCompletedBreast Cancer | Lung Cancer | GI CancerUnited States
-
Walter Reed Army Medical CenterAmerican Society of Health-System PharmacistsCompletedHypertension | Medication Adherence | HyperlipidemiaUnited States
-
University of Wisconsin, MadisonAmerican Society of Health-System Pharmacists; William S. Middleton Memorial...CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
University Hospital, ToulouseRecruiting
-
Hospital de Clinicas de Porto AlegreCompleted
-
The Miriam HospitalNational Institute on Aging (NIA)Recruiting
-
Massachusetts General HospitalActive, not recruiting
-
Baylor College of MedicineM.D. Anderson Cancer Center; Harris County Hospital District; Texas A&M University and other collaboratorsCompleted